Transcranial Magneto-Acoustic Stimulation Protects Synaptic Rehabilitation from Amyloid-Beta Plaques via Regulation of Microglial Functions
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25094651 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Chunlan Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, 236# Baidi Road, Tianjin 300192, China. Hauptthemen laut MEDLINE: Microglia, Plaque, Amyloid, Alzheimer Disease, Amyloid beta-Peptides. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China, National key research and development plan, Chinese Academy of Medical Sciences Medical and Health Science and Technology Innovation Project Mission Statement.
Abstract (Originalsprache)
Transcranial magneto-acoustic stimulation (TMAS), which is characterized by high spatiotemporal resolution and high penetrability, is a non-invasive neuromodulation technology based on the magnetic–acoustic coupling effect. To reveal the effects of TMAS treatment on amyloid-beta (Aβ) plaque and synaptic plasticity in Alzheimer’s disease, we conducted a comparative analysis of TMAS and transcranial ultrasound stimulation (TUS) based on acoustic effects in 5xFAD mice and BV2 microglia cells. We found that the TMAS-TUS treatment effectively reduced amyloid plaque loads and plaque-associated neurotoxicity. Additionally, TMAS-TUS treatment ameliorated impairments in long-term memory formation and long-term potentiation. Moreover, TMAS-TUS treatment stimulated microglial proliferation and migration while enhancing the phagocytosis and clearance of Aβ. In 5xFAD mice with induced microglial exhaustion, TMAS-TUS treatment-mediated Aβ plaque reduction, synaptic rehabilitation improvement, and the increase in phospho-AKT levels were diminished. Overall, our study highlights that stimulation of hippocampal microglia by TMAS treatment can induce anti-cognitive impairment effects via PI3K-AKT signaling, providing hope for the development of new strategies for an adjuvant therapy for Alzheimer’s disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, 236# Baidi Road, Tianjin 300192, China.
- Tianjin Institutes of Health Science, Tianjin 301600, China.
ORCID-Profile: Ren Ma
Förderung
- Natural Science Foundation of China
- National key research and development plan
- Chinese Academy of Medical Sciences Medical and Health Science and Technology Innovation Project Mission Statement
- Peking Union Medical College Graduate Innovation Fund
- Beijing-Tianjin-Hebei Basic Research Cooperation Special Project
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Zhang, C., Tan, R., Zhou, X., Wang, R., Wang, X., Ma, R., Chu, F., Li, Y., Yin, T., & Liu, Z. (2024). Transcranial Magneto-Acoustic Stimulation Protects Synaptic Rehabilitation from Amyloid-Beta Plaques via Regulation of Microglial Functions. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25094651
Vancouver
Zhang C, Tan R, Zhou X, Wang R, Wang X, Ma R, et al. Transcranial Magneto-Acoustic Stimulation Protects Synaptic Rehabilitation from Amyloid-Beta Plaques via Regulation of Microglial Functions. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25094651
BibTeX
@article{Zhang2024,
author = {Zhang, Chunlan and Tan, Ruxin and Zhou, Xiaoqing and Wang, Ruru and Wang, Xin and Ma, Ren and Chu, Fangxuan and Li, Ying and Yin, Tao and Liu, Zhipeng},
title = {Transcranial Magneto-Acoustic Stimulation Protects Synaptic Rehabilitation from Amyloid-Beta Plaques via Regulation of Microglial Functions},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25094651}
}
EUVIMED